Cargando…

Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight

Obesity is a major cause of type 2 diabetes. Transition from obesity to type 2 diabetes manifests in the dysregulation of hormones controlling glucose homeostasis and inflammation. As metabolism is a dynamic process that changes across 24 h, we assessed diurnal rhythmicity in a panel of 10 diabetes-...

Descripción completa

Detalles Bibliográficos
Autores principales: Isherwood, Cheryl M, Robertson, M Denise, Skene, Debra J, Johnston, Jonathan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620456/
https://www.ncbi.nlm.nih.gov/pubmed/37855336
http://dx.doi.org/10.1530/EC-23-0064
_version_ 1785130209806123008
author Isherwood, Cheryl M
Robertson, M Denise
Skene, Debra J
Johnston, Jonathan D
author_facet Isherwood, Cheryl M
Robertson, M Denise
Skene, Debra J
Johnston, Jonathan D
author_sort Isherwood, Cheryl M
collection PubMed
description Obesity is a major cause of type 2 diabetes. Transition from obesity to type 2 diabetes manifests in the dysregulation of hormones controlling glucose homeostasis and inflammation. As metabolism is a dynamic process that changes across 24 h, we assessed diurnal rhythmicity in a panel of 10 diabetes-related hormones. Plasma hormones were analysed every 2 h over 24 h in a controlled laboratory study with hourly isocaloric drinks during wake. To separate effects of body mass from type 2 diabetes, we recruited three groups of middle-aged men: an overweight (OW) group with type 2 diabetes and two control groups (lean and OW). Average daily concentrations of glucose, triacylglycerol and all the hormones except visfatin were significantly higher in the OW group compared to the lean group (P < 0.001). In type 2 diabetes, glucose, insulin, C-peptide, glucose-dependent insulinotropic peptide and glucagon-like peptide-1 increased further (P < 0.05), whereas triacylglycerol, ghrelin and plasminogen activator inhibitor-1 concentrations were significantly lower compared to the OW group (P < 0.001). Insulin, C-peptide, glucose-dependent insulinotropic peptide and leptin exhibited significant diurnal rhythms in all study groups (P < 0.05). Other hormones were only rhythmic in 1 or 2 groups. In every group, hormones associated with glucose regulation (insulin, C-peptide, glucose-dependent insulinotropic peptide, ghrelin and plasminogen activator inhibitor-1), triacylglycerol and glucose peaked in the afternoon, whereas glucagon and hormones associated with appetite and inflammation peaked at night. Thus being OW with or without type 2 diabetes significantly affected hormone concentrations but did not affect the timing of the hormonal rhythms.
format Online
Article
Text
id pubmed-10620456
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-106204562023-11-03 Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight Isherwood, Cheryl M Robertson, M Denise Skene, Debra J Johnston, Jonathan D Endocr Connect Research Obesity is a major cause of type 2 diabetes. Transition from obesity to type 2 diabetes manifests in the dysregulation of hormones controlling glucose homeostasis and inflammation. As metabolism is a dynamic process that changes across 24 h, we assessed diurnal rhythmicity in a panel of 10 diabetes-related hormones. Plasma hormones were analysed every 2 h over 24 h in a controlled laboratory study with hourly isocaloric drinks during wake. To separate effects of body mass from type 2 diabetes, we recruited three groups of middle-aged men: an overweight (OW) group with type 2 diabetes and two control groups (lean and OW). Average daily concentrations of glucose, triacylglycerol and all the hormones except visfatin were significantly higher in the OW group compared to the lean group (P < 0.001). In type 2 diabetes, glucose, insulin, C-peptide, glucose-dependent insulinotropic peptide and glucagon-like peptide-1 increased further (P < 0.05), whereas triacylglycerol, ghrelin and plasminogen activator inhibitor-1 concentrations were significantly lower compared to the OW group (P < 0.001). Insulin, C-peptide, glucose-dependent insulinotropic peptide and leptin exhibited significant diurnal rhythms in all study groups (P < 0.05). Other hormones were only rhythmic in 1 or 2 groups. In every group, hormones associated with glucose regulation (insulin, C-peptide, glucose-dependent insulinotropic peptide, ghrelin and plasminogen activator inhibitor-1), triacylglycerol and glucose peaked in the afternoon, whereas glucagon and hormones associated with appetite and inflammation peaked at night. Thus being OW with or without type 2 diabetes significantly affected hormone concentrations but did not affect the timing of the hormonal rhythms. Bioscientifica Ltd 2023-10-12 /pmc/articles/PMC10620456/ /pubmed/37855336 http://dx.doi.org/10.1530/EC-23-0064 Text en © the author(s) https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Research
Isherwood, Cheryl M
Robertson, M Denise
Skene, Debra J
Johnston, Jonathan D
Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight
title Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight
title_full Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight
title_fullStr Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight
title_full_unstemmed Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight
title_short Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight
title_sort daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620456/
https://www.ncbi.nlm.nih.gov/pubmed/37855336
http://dx.doi.org/10.1530/EC-23-0064
work_keys_str_mv AT isherwoodcherylm dailyrhythmsofdiabetogenicfactorsinmenroleoftype2diabetesandbodyweight
AT robertsonmdenise dailyrhythmsofdiabetogenicfactorsinmenroleoftype2diabetesandbodyweight
AT skenedebraj dailyrhythmsofdiabetogenicfactorsinmenroleoftype2diabetesandbodyweight
AT johnstonjonathand dailyrhythmsofdiabetogenicfactorsinmenroleoftype2diabetesandbodyweight